Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression
Jia Gao,1,* Ziteng Zhang,2,* Hong Su,1 Ling Zong,2 Yan Li1 1Department of Thoracic Surgery, Heze Municipal Hospital, Heze, Shandong 274031, People’s Republic of China; 2Department of Thoracic Surgery, Affiliated Hospital of Jining Medical University, Shandong 272000, People’s Rep...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous-rna-on-micr-peer-reviewed-article-CMAR |
id |
doaj-9430d66b84dc4231986cd4fa1a048f1a |
---|---|
record_format |
Article |
spelling |
doaj-9430d66b84dc4231986cd4fa1a048f1a2020-11-25T01:48:28ZengDove Medical PressCancer Management and Research1179-13222020-03-01Volume 122265227852736Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 ExpressionGao JZhang ZSu HZong LLi YJia Gao,1,* Ziteng Zhang,2,* Hong Su,1 Ling Zong,2 Yan Li1 1Department of Thoracic Surgery, Heze Municipal Hospital, Heze, Shandong 274031, People’s Republic of China; 2Department of Thoracic Surgery, Affiliated Hospital of Jining Medical University, Shandong 272000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yan LiDepartment of Thoracic Surgery, Heze Municipal Hospital, No. 2888 Caozhou West Road, Heze, Shandong 274031, People’s Republic of ChinaEmail yanli_heze@163.comPurpose: Previous studies have identified the important roles of a long noncoding RNA called FGD5 antisense RNA 1 (FGD5-AS1) in several types of human cancer. Nonetheless, to our knowledge, the expression and functions of FGD5-AS1 in esophageal squamous cell carcinoma (ESCC) have not been clarified. In this study, we aimed to determine the expression status of long noncoding RNA FGD5-AS1 in ESCC, determine its participation in ESCC progression, and uncover the underlying mechanisms.Methods: ESCC tissue samples and paired normal adjacent tissues were collected to quantify FGD5-AS1 expression by reverse-transcription quantitative PCR. The effects of FGD5-AS1 on ESCC cell proliferation, apoptosis, migration, and invasion in vitro as well as tumor growth in vivo were studied using a Cell Counting Kit-8 assay, flow cytometry, Transwell migration and invasion assays, and an in vivo tumor xenograft experiment.Results: FGD5-AS1 was found to be aberrantly upregulated in both ESCC tumors and cell lines compared to the control groups. Increased FGD5-AS1 expression manifested a close association with tumor size, TNM stage, and lymph node metastasis in patients with ESCC. Overall survival of patients with ESCC was shorter in the FGD5-AS1 high-expression group than in the FGD5-AS1 low-expression group. An FGD5-AS1 knockdown markedly attenuated ESCC cell proliferation, migration, and invasion and promoted apoptosis in vitro as well as slowed tumor growth in vivo. Mechanism investigation revealed that FGD5-AS1 can increase SP1 expression by sponging microRNA-383 (miR-383), thus functioning as a competing endogenous RNA. An miR-383 knockdown and recovery of SP1 expression attenuated the inhibition of the malignant characteristics of ESCC cells by the FGD5-AS1 knockdown.Conclusion: Thus, FGD5-AS1 enhances the aggressive phenotype of ESCC cells in vitro and in vivo via the miR-383–SP1 axis, which may represent a novel target for ESCC therapy.Keywords: esophageal squamous cell carcinoma, FGD5 antisense RNA 1, microRNA-383 https://www.dovepress.com/long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous-rna-on-micr-peer-reviewed-article-CMAResophageal squamous cell carcinomafgd5 antisense rna 1microrna-383 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gao J Zhang Z Su H Zong L Li Y |
spellingShingle |
Gao J Zhang Z Su H Zong L Li Y Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression Cancer Management and Research esophageal squamous cell carcinoma fgd5 antisense rna 1 microrna-383 |
author_facet |
Gao J Zhang Z Su H Zong L Li Y |
author_sort |
Gao J |
title |
Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression |
title_short |
Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression |
title_full |
Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression |
title_fullStr |
Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression |
title_full_unstemmed |
Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression |
title_sort |
long noncoding rna fgd5-as1 acts as a competing endogenous rna on microrna-383 to enhance the malignant characteristics of esophageal squamous cell carcinoma by increasing sp1 expression |
publisher |
Dove Medical Press |
series |
Cancer Management and Research |
issn |
1179-1322 |
publishDate |
2020-03-01 |
description |
Jia Gao,1,* Ziteng Zhang,2,* Hong Su,1 Ling Zong,2 Yan Li1 1Department of Thoracic Surgery, Heze Municipal Hospital, Heze, Shandong 274031, People’s Republic of China; 2Department of Thoracic Surgery, Affiliated Hospital of Jining Medical University, Shandong 272000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yan LiDepartment of Thoracic Surgery, Heze Municipal Hospital, No. 2888 Caozhou West Road, Heze, Shandong 274031, People’s Republic of ChinaEmail yanli_heze@163.comPurpose: Previous studies have identified the important roles of a long noncoding RNA called FGD5 antisense RNA 1 (FGD5-AS1) in several types of human cancer. Nonetheless, to our knowledge, the expression and functions of FGD5-AS1 in esophageal squamous cell carcinoma (ESCC) have not been clarified. In this study, we aimed to determine the expression status of long noncoding RNA FGD5-AS1 in ESCC, determine its participation in ESCC progression, and uncover the underlying mechanisms.Methods: ESCC tissue samples and paired normal adjacent tissues were collected to quantify FGD5-AS1 expression by reverse-transcription quantitative PCR. The effects of FGD5-AS1 on ESCC cell proliferation, apoptosis, migration, and invasion in vitro as well as tumor growth in vivo were studied using a Cell Counting Kit-8 assay, flow cytometry, Transwell migration and invasion assays, and an in vivo tumor xenograft experiment.Results: FGD5-AS1 was found to be aberrantly upregulated in both ESCC tumors and cell lines compared to the control groups. Increased FGD5-AS1 expression manifested a close association with tumor size, TNM stage, and lymph node metastasis in patients with ESCC. Overall survival of patients with ESCC was shorter in the FGD5-AS1 high-expression group than in the FGD5-AS1 low-expression group. An FGD5-AS1 knockdown markedly attenuated ESCC cell proliferation, migration, and invasion and promoted apoptosis in vitro as well as slowed tumor growth in vivo. Mechanism investigation revealed that FGD5-AS1 can increase SP1 expression by sponging microRNA-383 (miR-383), thus functioning as a competing endogenous RNA. An miR-383 knockdown and recovery of SP1 expression attenuated the inhibition of the malignant characteristics of ESCC cells by the FGD5-AS1 knockdown.Conclusion: Thus, FGD5-AS1 enhances the aggressive phenotype of ESCC cells in vitro and in vivo via the miR-383–SP1 axis, which may represent a novel target for ESCC therapy.Keywords: esophageal squamous cell carcinoma, FGD5 antisense RNA 1, microRNA-383
|
topic |
esophageal squamous cell carcinoma fgd5 antisense rna 1 microrna-383 |
url |
https://www.dovepress.com/long-noncoding-rna-fgd5-as1-acts-as-a-competing-endogenous-rna-on-micr-peer-reviewed-article-CMAR |
work_keys_str_mv |
AT gaoj longnoncodingrnafgd5as1actsasacompetingendogenousrnaonmicrorna383toenhancethemalignantcharacteristicsofesophagealsquamouscellcarcinomabyincreasingsp1expression AT zhangz longnoncodingrnafgd5as1actsasacompetingendogenousrnaonmicrorna383toenhancethemalignantcharacteristicsofesophagealsquamouscellcarcinomabyincreasingsp1expression AT suh longnoncodingrnafgd5as1actsasacompetingendogenousrnaonmicrorna383toenhancethemalignantcharacteristicsofesophagealsquamouscellcarcinomabyincreasingsp1expression AT zongl longnoncodingrnafgd5as1actsasacompetingendogenousrnaonmicrorna383toenhancethemalignantcharacteristicsofesophagealsquamouscellcarcinomabyincreasingsp1expression AT liy longnoncodingrnafgd5as1actsasacompetingendogenousrnaonmicrorna383toenhancethemalignantcharacteristicsofesophagealsquamouscellcarcinomabyincreasingsp1expression |
_version_ |
1725012023982424064 |